Vaccines
CT-P63 demonstrated a well- established safety profile in the global Phase I trial CT-P63 maintained strong neutralising ability against the Omicron var...
January 04, 2022 | News
A team of scientists led by Dr. Su-Jun Deng from biologics of Jemincare R&D Center, and another team of scientists from SIMM of CAS, led by P...
January 04, 2022 | News
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
December 29, 2021 | News
Japan’s Ministry of Health, Labor and Welfare Approves Molnupiravir for the Treatment of SARS-CoV-2 Infection Molnupiravir, First Oral COVID-19 Anti...
December 27, 2021 | News
The vaccine belongs to the latest fifth generation vaccine technology, targeting the S-RBD protein of the COVID-19 mutant strain, the trimer subunit vaccin...
December 27, 2021 | News
Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG...
December 23, 2021 | News
SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised persons - Recommendation follows grant of WHO Emergency Use Li...
December 22, 2021 | News
Novavax and the European Commission previously announced an advance purchase agreement for up to 200 million doses through 2023 Authorization follows po...
December 21, 2021 | News
Brand Institute is proud to announce its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SPIKEVAX®. The brand nam...
December 20, 2021 | News
After successfully isolating the SARS-CoV-2 Omicron variant from clinical specimens, researchers at the Department of Microbiology at The University of Hon...
December 14, 2021 | News
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the interim recommendation by the Strategic Advisory Group of Experts on Immunization ...
December 10, 2021 | News
"Vaccination and getting a booster when eligible, along with other preventive measures like masking and avoiding large crowds and poorly ventilated spaces,...
December 10, 2021 | News
Sino Biological's new Omicron product line includes recombinant Omicron Spike proteins (RBD, S1, and S-ECD trimer), monoclonal antibodies&nb...
December 08, 2021 | News
Australian biotech company Starpharma has signed a 5-year supply and distribution arrangement for its VIRALEZE™ antiviral nasal spray in&nb...
December 06, 2021 | News
Most Read
Bio Jobs
News
Editor Picks